About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Regulatory and Clinical

Catalyst Category

Regulatory and Clinical

Live feed of every catalyst classified under Regulatory and Clinical.

CATALYSTS IN FEED

168

AVG MAX MOVE

+116.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

DSMB Efficacy Met FDA 510(k) Cleared FDA Approval FDA Fast Track FDA Meeting FDA Meeting Granted Generic Drug Approved Inconclusive Topline Results IND Cleared for Study IND Filed NDA Resubmission Orphan Drug Designation Positive Subgroup Data Positive Topline Results Primary Endpoint Met SPA Agreement Study Complete Trial Enrollment Complete

Range–

Showing 7 of 168

Regulatory and ClinicalJul 21, 2025 · 4:00am ET

IXHLIncannex Healthcare Inc.

Incannex Healthcare Completes US Phase 2 Trial for OSA Drug Candidate

The trial focused on a dual-mechanism drug targeting Obstructive Sleep Apnea.

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+54.6%

RVOL

6.5x

Max high

$29.75

Fuel

3h 24m

Regulatory and ClinicalJul 21, 2025 · 4:00am ET

IXHLIncannex Healthcare Inc.+54.6%

Incannex Healthcare Completes US Phase 2 Trial for OSA Drug Candidate

RVOL

6.5x

Max high

$29.75

Fuel

3h 24m

Regulatory and ClinicalJul 14, 2025 · 7:57pm ET

KAPAKairos Pharma, Ltd.

Kairos Pharma Announces Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer

Results compared to Standard of Care Hormone Therapy.

Regulatory and ClinicalJul 14, 2025 · 7:57pm ET

KAPAKairos Pharma, Ltd.+174.4%

Kairos Pharma Announces Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer

Regulatory and ClinicalJul 14, 2025 · 5:02am ET

RANIRani Therapeutics Holdings, Inc.

Rani Therapeutics and ProGen Demonstrate Bioequivalence of Oral GLP-1/GLP-2 Agonist

Late breaking presentation at ENDO 2025

Regulatory and ClinicalJul 14, 2025 · 5:02am ET

RANIRani Therapeutics Holdings, Inc.+72.1%

Rani Therapeutics and ProGen Demonstrate Bioequivalence of Oral GLP-1/GLP-2 Agonist

Regulatory and ClinicalJul 7, 2025 · 7:59pm ET

CNSYPLUS THERAPEUTICS, Inc. Common Stock

Plus Therapeutics Begins Treating Patients in ReSPECT-LM Dose Optimization Trial for REYOBIQ

The trial focuses on Leptomeningeal Metastases.

Regulatory and ClinicalJul 7, 2025 · 7:59pm ET

CNSYPLUS THERAPEUTICS, Inc. Common Stock+60.4%

Plus Therapeutics Begins Treating Patients in ReSPECT-LM Dose Optimization Trial for REYOBIQ

Regulatory and ClinicalJun 23, 2025 · 7:59pm ET

INMInMed Pharmaceuticals Inc. Common Shares

InMed Pharmaceuticals Announces Preclinical Data for INM-901

Company reports significant reduction in neuroinflammation in Alzheimer's disease.

Regulatory and ClinicalJun 23, 2025 · 7:59pm ET

INMInMed Pharmaceuticals Inc. Common Shares+123.6%

InMed Pharmaceuticals Announces Preclinical Data for INM-901

Regulatory and ClinicalJun 23, 2025 · 5:37pm ET

TRIBTrinity Biotech plc

Trinity Biotech Receives WHO Approval for TrinScreen HIV Rapid Test Manufacturing

Approval granted for offshored and outsourced upstream manufacturing activities.

Regulatory and ClinicalJun 23, 2025 · 5:37pm ET

TRIBTrinity Biotech plc+84.1%

Trinity Biotech Receives WHO Approval for TrinScreen HIV Rapid Test Manufacturing

Regulatory and ClinicalJun 23, 2025 · 4:15pm ET

IBIOiBio, Inc. Common Stock

iBio Presented Next-Generation Obesity and Cardiometabolic Pipeline Candidates

Company showcased advancements during a conference call.

Regulatory and ClinicalJun 23, 2025 · 4:15pm ET

IBIOiBio, Inc. Common Stock+99.0%

iBio Presented Next-Generation Obesity and Cardiometabolic Pipeline Candidates

1
…
17
18
19
…
24

RVOL

1.4x

Max high

$13.16

Fuel

1h 33m

RVOL

13.3x

Max high

$1.18

Fuel

32m

RVOL

9.5x

Max high

$12.05

Fuel

2h 2m

RVOL

12.8x

Max high

$5.50

Fuel

2h 59m

RVOL

6.6x

Max high

$30.90

Fuel

3m

RVOL

12.5x

Max high

$1.45

Fuel

3h 46m